General Electric Co. Stock
The price for the General Electric Co. stock decreased slightly today. Compared to yesterday there is a change of -€0.086 (-0.900%).
With 8 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
With a target price of €14.00 there is a positive potential of 47.306% for General Electric Co. compared to the current price of €9.50.
So far the community has only identified positive things for General Electric Co. stock. The most positive votes were given for criterium "Debt".
With 8 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
With a target price of €14.00 there is a positive potential of 47.306% for General Electric Co. compared to the current price of €9.50.
So far the community has only identified positive things for General Electric Co. stock. The most positive votes were given for criterium "Debt".
Pros and Cons of General Electric Co. in the next few years
Pros
1
Normal challenges to pay loans and raise capital
1
Revenue growth >5% per year expected
1
Could be worthwhile Investment >10% per year
Cons
0
-
Performance of General Electric Co. vs. its peers
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| General Electric Co. | -0.900% | 4.330% | 7.608% | -11.253% | 11.008% | -37.646% | -64.216% |
| 3M Company | -0.530% | -1.084% | -3.958% | -16.008% | -3.877% | -31.920% | 4.794% |
| Illinois Tool Works | -1.010% | -0.996% | 2.787% | 5.221% | 3.126% | 19.787% | 121.363% |
| Honeywell International | -0.080% | -1.004% | -1.606% | 5.810% | 0.551% | 31.969% | 91.049% |
Comments
Buy General Electric Co.
Buy General Electric Co.
Other discussions about General Electric Co. Stock
Trading General Electric Co.
Trading General Electric Co.
News
![GE Healthcare, GenesisCare Partner to Tackle Two Biggest Health Burdens Globally, Deliver Improved Cancer and Cardiovascular Care to Patients Around the Worldhttp://upload.wikimedia.org/wikipedia/commons/e/e4/General_electric.jpg: Thomas Edison [Public domain], via Wikimedia Commons](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBY2s9IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--302e87e29a2a39c997ad94ba42c8e186717a80e2/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/General_electric.jpg?locale=us)
GE Healthcare, GenesisCare Partner to Tackle Two Biggest Health Burdens Globally, Deliver Improved Cancer and Cardiovascular Care to Patients Around the World
GE Healthcare, the leading global provider of advanced medical imaging, and GenesisCare, a leading provider of integrated cancer care globally and cardiovascular care in Australia, today announced
GE Digital 2020 User Conference: From Resilience to Innovation
GE Digital today begins a three-day virtual User Conference featuring stories of companies in multiple industries on their path to digital transformation: enabling more renewable energy on the
GE Healthcare’s Clariscan™ (gadoterate meglumine) Becomes Only FDA-Approved MRI Contrast Agent Available in Polymer Bottle
GE Healthcare’s innovative shatterproof polymer +PLUSPAK Pharmacy Bulk Package has been approved by the US FDA for use with its macrocyclic gadolinium-based MRI contrast agent, Clariscan